[1]
“An Update on the Innovative Mechanistic Modes for the Avoidance of Heart Failure with Preserved Ejection Fraction Using Glucagon Like Peptide 1 Receptor Agonism Particularly in Type 2 Diabetes Mellitus & Metabolic Syndrome: A Review: Review Article”, IJRMCS, vol. 3, no. 02, pp. 04–28, Aug. 2025, doi: 10.70829/ijrmcs.v03.i02.002.